A carregar...

Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins

Mipomersen, an antisense oligonucleotide that reduces hepatic production of apoB, has been shown in phase 2 studies to decrease plasma apoB, LDL cholesterol (LDL-C), and triglycerides. ApoC-III inhibits VLDL and LDL clearance, and it stimulates inflammatory responses in vascular cells. Concentration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Furtado, Jeremy D., Wedel, Mark K., Sacks, Frank M.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Biochemistry and Molecular Biology 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3307655/
https://ncbi.nlm.nih.gov/pubmed/22301884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.P021717
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!